SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.8503
-0.0297 (-3.38%)
Aug 12, 2025, 4:00 PM - Market closed
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $33.18 million as of August 12, 2025. Its market cap has decreased by -57.89% in one year.
Market Cap
33.18M
Enterprise Value
-4.94M
1-Year Change
-57.89%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $33.18M, a decrease of -56.40%. That is a compound annual growth rate of -7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 34.30M | -25.27% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
| May 2, 2014 | 76.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |